Procurement Summary
Country: Serbia
Summary: Medicines Outside the List of Medicines
Deadline: 19 Jun 2026
Posting Date: 04 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142623200
Document Ref. No.: A313/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Amivantamab, Anifrolumab, Avelumab, Benralizumab, Budesonide, Eculizumab, Eravacycline, Erenumab, Esketamine, Human hemin, Alpha 1 proteinase inhibitor, Levodopa/carbidopa/entacapone, Lorlatinib, Nintedanib, Omalizumab, Paclitaxel, Pegaspargase, Seladelpar, Talquetamab, Teklistamab
Status of the procedure: Ordering party UNIVERSITY CLINICAL CENTER OF SERBIA Ordering location RS110 - Belgrade region, BELGRADE Name of procurement Medicines outside the list of medicines Reference number A313/2026 Item type Good Estimated value Type of procedure Open procedure Deadline for submission 19.06.2026 09:00:00 Status of the procedure Published Deadline for submission: 19.06.2026 09:00:00
Documents
Tender Notice